These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12234314)

  • 1. C-reactive protein and cardiovascular disease in peritoneal dialysis patients.
    Ducloux D; Bresson-Vautrin C; Kribs M; Abdelfatah A; Chalopin JM
    Kidney Int; 2002 Oct; 62(4):1417-22. PubMed ID: 12234314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.
    Böger CA; Götz A; Stubanus M; Banas B; Deinzer M; Krüger B; Holmer SR; Schmitz G; Riegger GA; Krämer BK
    Kidney Int; 2005 Jul; 68(1):217-27. PubMed ID: 15954911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of C-reactive protein levels in peritoneal dialysis patients.
    Fine A
    Kidney Int; 2002 Feb; 61(2):615-20. PubMed ID: 11849404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
    Avram MM; Fein PA; Paluch MM; Schloth T; Chattopadhyay J
    Adv Perit Dial; 2005; 21():154-8. PubMed ID: 16686309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.
    Stefoni S; Cianciolo G; Donati G; Dormi A; Silvestri MG; Colì L; De Pascalis A; Iannelli S
    Kidney Int; 2002 Jan; 61(1):324-35. PubMed ID: 11786115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Goggins WB; Yu CM; Lui SF; Sanderson JE
    Clin Chem; 2007 May; 53(5):882-9. PubMed ID: 17395709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.
    Koo HM; Do HM; Kim EJ; Lee MJ; Shin DH; Kim SJ; Oh HJ; Yoo DE; Kim JK; Park JT; Han SH; Kang SW; Choi KH; Yoo TH
    Atherosclerosis; 2011 Dec; 219(2):925-30. PubMed ID: 22015178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study.
    Nascimento MM; Pecoits-Filho R; Qureshi AR; Hayashi SY; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Lindholm B; Riella MC
    Nephrol Dial Transplant; 2004 Nov; 19(11):2803-9. PubMed ID: 15496560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
    Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
    J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
    Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
    Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
    Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
    Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.